Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
BC-3195 by BioCity Biopharma for Metastatic Ovarian Cancer: Likelihood of Approval
BC-3195 is under clinical development by BioCity Biopharma and currently in Phase I for Metastatic Ovarian Cancer. According to GlobalData,...